Emory Eye Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Melanoma2 trials
• Diabetic eye disease1 trial
• Macular degeneration1 trial
• Retinitis pigmentosa1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Aura Biosciences2 trials
• Jaeb Center for Health Research2 trials
• VisionCare, Inc.1 trial

Running trials

• Recruiting

  Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  NCT06790784· Phase 3· Jaeb Center for Health Research· Source

  Contact: Andrew M Hendrick, MD

• Active, not recruiting

  A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

  NCT06007690· Phase 3· Aura Biosciences· Source

• Active, not recruiting

  Rate of Progression in EYS Related Retinal Degeneration

  NCT04127006· Jaeb Center for Health Research· Source

• Enrolling by invitation

  Post-Approval Study of the Implantable Miniature Telescope

  NCT01757132· VisionCare, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diabetic eye disease1 recruiting
• Macular degeneration1 recruiting

Closed trials

• Completed

  Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

  NCT04417530· Phase 2· Aura Biosciences· Source